Isola S. Antonio, Italy

Pier G Pagella


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 48(Granted Patents)


Location History:

  • Isola S. Antonio, IT (1989 - 1993)
  • Fraz. Catraglia, IT (1993)
  • Isola San Antonio, IT (1994)
  • Frazione Catraglia, IT (1994)
  • Catraglia, IT (1994 - 1995)
  • Isola Sant'Antonio, IT (1999)

Company Filing History:


Years Active: 1989-1999

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pier G Pagella

Introduction

Pier G Pagella is a notable inventor based in Isola S. Antonio, Italy. He has made significant contributions to the field of chemistry, particularly in the development of compounds that serve as cholinesterase activity inhibitors. With a total of 11 patents to his name, Pagella's work has had a considerable impact on pharmaceutical research.

Latest Patents

Among his latest patents are several innovative compounds, including phenylcarbamate derivatives suitable for use as anticholinesterase agents. He has also developed processes for preparing aminoalkylcarbamic esters of eseroline, which are crucial for creating effective cholinesterase inhibitors. These compounds are characterized by a general formula where R represents an amine selected from a specific group, with additional variables defined in his patent documentation.

Career Highlights

Throughout his career, Pagella has worked with prominent companies in the pharmaceutical industry, including Mediolanum Farmaceutici S.p.a. and Mediolanum Farmaceutici, S.r.l. His work in these organizations has allowed him to advance his research and contribute to the development of new therapeutic agents.

Collaborations

Pagella has collaborated with esteemed colleagues such as Stefano Maiorana and Mario Brufani. These partnerships have fostered a collaborative environment that has enhanced the innovation process in their respective fields.

Conclusion

Pier G Pagella's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…